Cosmo Bio Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: JP3298700000
JPY
1,244.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
3,331.00
2,881.00
2,483.00
2,309.00
3,093.00
2,628.00
2,280.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,331.00
2,881.00
2,483.00
2,309.00
3,093.00
2,628.00
2,280.00
Raw Material Cost
2,195.00
1,916.00
1,612.00
1,502.00
2,034.00
1,770.00
1,522.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
864.00
898.00
871.00
805.00
785.00
908.00
713.00
Other Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
3,059.00
2,814.00
2,483.00
2,307.00
2,819.00
2,678.00
2,235.00
Operating Profit (PBDIT) excl Other Income
272
67
0
2
274
-50
45
Other Income
61.00
88.00
16.00
48.00
43.00
6.00
29.00
Operating Profit (PBDIT)
379.00
209.00
57.00
88.00
351.00
-4.00
108.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
3.00
-47.00
10.00
-1.00
4.00
-25.00
-27.00
Gross Profit (PBDT)
1,136.00
965.00
871.00
807.00
1,059.00
858.00
758.00
Depreciation
46.00
54.00
41.00
38.00
34.00
40.00
34.00
Profit Before Tax
335.00
107.00
26.00
50.00
321.00
-69.00
48.00
Tax
102.00
51.00
4.00
14.00
101.00
-37.00
13.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
223.00
63.00
23.00
37.00
213.00
-29.00
32.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
223.00
63.00
23.00
37.00
213.00
-29.00
32.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
10.00
-7.00
-1.00
-2.00
7.00
-3.00
2.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
233.00
56.00
22.00
35.00
220.00
-32.00
34.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
9,459.00
9,373.00
9,279.00
9,084.00
8,763.00
8,968.00
8,889.00
Earnings per share (EPS)
39.13
11.46
3.93
6.68
37.12
-5.06
5.69
Diluted Earnings per share
39.13
11.46
3.93
6.68
37.12
-5.06
5.69
Operating Profit Margin (Excl OI)
8.17%
2.33%
0.0%
0.09%
8.86%
-1.9%
1.97%
Gross Profit Margin
11.44%
5.59%
2.7%
3.81%
11.48%
-1.1%
3.6%
PAT Margin
6.69%
2.19%
0.93%
1.6%
6.89%
-1.1%
1.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.69% vs 5.10% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 5.91% vs -8.33% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 3.25% vs -8.33% in Mar 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Cosmo Bio Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
3,331.00
3,699.00
-368.00
-9.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,331.00
3,699.00
-368.00
-9.95%
Raw Material Cost
2,195.00
850.00
1,345.00
158.24%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
5.00
-5.00
-100.00%
Selling and Distribution Expenses
864.00
2,798.00
-1,934.00
-69.12%
Other Expenses
0.00
-0.50
0.50
100.00%
Total Expenditure (Excl Depreciation)
3,059.00
3,648.00
-589.00
-16.15%
Operating Profit (PBDIT) excl Other Income
272.00
51.00
221.00
433.33%
Other Income
61.00
17.00
44.00
258.82%
Operating Profit (PBDIT)
379.00
143.00
236.00
165.03%
Interest
0.00
5.00
-5.00
-100.00%
Exceptional Items
3.00
7.00
-4.00
-57.14%
Gross Profit (PBDT)
1,136.00
2,849.00
-1,713.00
-60.13%
Depreciation
46.00
75.00
-29.00
-38.67%
Profit Before Tax
335.00
71.00
264.00
371.83%
Tax
102.00
35.00
67.00
191.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
223.00
37.00
186.00
502.70%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
223.00
37.00
186.00
502.70%
Share in Profit of Associates
0
0
0.00
Minority Interest
10.00
0.00
10.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
233.00
37.00
196.00
529.73%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
9,459.00
7,048.00
2,411.00
34.21%
Earnings per share (EPS)
39.13
4.24
34.89
822.88%
Diluted Earnings per share
39.13
4.24
34.89
822.88%
Operating Profit Margin (Excl OI)
8.17%
1.38%
0.00
6.79%
Gross Profit Margin
11.44%
3.95%
0.00
7.49%
PAT Margin
6.69%
1.00%
0.00
5.69%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 333.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 15.62% vs 16.03% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.69% vs 5.10% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 316.07% vs 154.55% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 5.91% vs -8.33% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 31.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 162.81% vs 195.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 3.25% vs -8.33% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.17%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025